Amplifon stock: AlphaValue lifts target to EUR 16.70 for Amplifon stock

Published on 10/22/2026 at 17:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

First-half revenue reached EUR 1.19 billion. Amplifon stock costs EUR 12.91 on October 22, 2026, up 0.94 percent versus the Borsa close.

Analyst target and reporting date

AlphaValue raised its Amplifon target from EUR 13.20 to EUR 16.70 and upgraded the stock to Buy on October 5, 2026.
First-half 2026 revenue reached EUR 1.19 billion, up 1.30 percent at constant exchange rates.
Amplifon stock costs EUR 12.91 at Lang & Schwarz on October 22, 2026 at 5:11 p.m. CEST, 0.94 percent above the Borsa Italiana close of October 21, 2026.
Amplifon is scheduled to publish third-quarter and nine-month results on October 29, 2026.

Aquarellmalerei der Mailänder Skyline mit Dom in weichen Pastelltönen — Aquarellgemälde der Mailänder Skyline symbolisiert den Hauptsitz von Amplifon S.p.A., ISIN IT0004056880, italienischer Gesundheitskonzern, Illustration mit AI erstellt.

Amplifon stock (ISIN IT0004056880) is trading at EUR 12.91 at Lang & Schwarz on October 22, 2026 at 5:11 p.m. CEST, 0.94 percent above the Borsa Italiana close of October 21, 2026. On October 5, 2026, AlphaValue raised its target for Amplifon from EUR 13.20 to EUR 16.70 and upgraded the stock to Buy, as reported by Ora Finanza. The new target lies 29.36 percent above the Lang & Schwarz price.

Growth supports the target case

Amplifon's first-half 2026 revenue reached EUR 1.19 billion, up 1.30 percent at constant exchange rates, while organic growth reached 3.50 percent. Adjusted EBITDA rose 3.60 percent to EUR 298.00 million and the adjusted EBITDA margin increased to 25.10 percent, according to Capital.com in its review of the July 30, 2026 results.

The figures give AlphaValue's higher target an operating reference point, but the improvement remains tied to execution. Capital.com reported adjusted free cash flow of EUR 68.00 million for the first half, up 70.00 percent from the first half of 2025, while reported EBITDA included one-off costs linked to the GN Hearing acquisition and restructuring.

Price position on October 22

Amplifon traded between EUR 7.84 and EUR 21.40 over the 52 weeks through October 22, 2026. The Lang & Schwarz price therefore stood 39.20 percent above the low and 39.72 percent below the high. Trading volume was 703,883 shares on the same date.

The price-to-earnings ratio was 42.58 and market capitalization was EUR 2.8 billion as of October 22, 2026. Both figures place the stock in a valuation discussion where the next operating update matters more than the daily move.

What dates matter next?

Amplifon is scheduled to publish its third-quarter and nine-month results on October 29, 2026, according to Morningstar. The same report gave Amplifon a fair value estimate of EUR 11.70 on October 21, 2026, below the Lang & Schwarz price.

MarketScreener listed 16 analysts with an average target of EUR 13.63 on October 22, 2026. Its high target was EUR 16.70 and its low target was EUR 11.10, showing a wide spread around the current quotation.

Comparison with peers

Amplifon: up 0.94 percent, price-to-earnings ratio 42.58, market capitalization EUR 2.8 billion.

Demant: down 2.69 percent, price-to-earnings ratio 45.91, market capitalization DKK 74.7 billion.

Sonova: up 1.59 percent, price-to-earnings ratio 38.95, market capitalization CHF 16.7 billion.

Stock remains below its yearly high

Amplifon's daily move was limited relative to its 52-week spread, while the analyst target range remains wide. At Lang & Schwarz, the stock stood at EUR 12.91 on October 22, 2026 at 5:11 p.m. CEST, up 0.94 percent versus the Borsa Italiana close of October 21, 2026 at EUR 12.79. The further course of trading is shown by the continuously updated real-time quote of Amplifon stock.